TY  - RPRT
TI  - Combinatorial approaches using an AI/ML-driven drug development platform targeting insulin resistance, lipid dysregulation, and inflammation for the amelioration of metabolic syndrome in patients
AU  - Khotimchenko, M.
AU  - Hixon, M. S.
AU  - Brunk, N. E.
AU  - Walden, D. M.
AU  - Hou, H.
AU  - Chakravarty, K.
AU  - Varshney, J.
PY  - 2021
DO  - 10.1101/2021.09.01.458488
UR  - https://www.biorxiv.org/content/10.1101/2021.09.01.458488v1
ID  - 10.1101/2021.09.01.458488
ER  -